Molecules / Gabapentin

Gabapentin API manufacturers

CAS 60142-96-3 ATC N03AX12 · Antiepileptics Updated 9 July 2026
34
manufacturers with an active filing 22 of them hold a US DMF or a CEP
$30.00
median export price per kg $25.00 to $40.00 · 55 exporters · 2025
339
shortage records on file across 13 countries
977
finished-dose makers across 56 regulators
Showing 20 of 34 manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked API manufacturers

04

Olon

Italy
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF and one valid CEP for gabapentin, filing since 2005. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 3 markets.

US DMF
1 active
CEP
1 valid
Last FDA inspection
2025 · VAI
GMP recognised in
3 markets
How this listing is sourced EDQM certificate database
FDA, List of Drug Master Files
View profile
05

Hetero

India
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026

Holds 4 active US DMFs for gabapentin, filing since 2012. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.

US DMF
4 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
6 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
06

Jiangxi Synergy Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds 2 active US DMFs for gabapentin, filing since 2012. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.

US DMF
2 active
CEP
None on file
Last FDA inspection
2025 · NAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
08

Granules India

India
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026

Holds 2 active US DMFs for gabapentin, filing since 2026. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 7 markets.

US DMF
2 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
7 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
09

Anjan Drug

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds 2 active US DMFs for gabapentin, filing since 2009. Its 2025 FDA inspection closed as NAI.

US DMF
2 active
CEP
None on file
Last FDA inspection
2025 · NAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
11

Apitoria Pharma

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF and 2 valid CEPs for gabapentin, filing since 2006. Its 2025 FDA inspection closed as VAI.

US DMF
1 active
CEP
2 valid
Last FDA inspection
2025 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
13

Zhejiang Excel Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for gabapentin, filing since 2012. Its 2024 FDA inspection closed as NAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2024 · NAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
14

Erregierre

Italy
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for gabapentin, filing since 2018. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.

US DMF
None on file
CEP
1 valid
Last FDA inspection
2025 · NAI
GMP recognised in
1 markets
How this listing is sourced EDQM certificate database
View profile
15
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for gabapentin, filing since 1999. Its 2022 FDA inspection closed as VAI, and its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
2022 · VAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
17

Emnar Pharma

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds 2 active US DMFs for gabapentin, filing since 2022. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.

US DMF
2 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
2 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
18

IOL Chemicals and Pharmaceuticals

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for gabapentin, filing since 2024. Its 2019 FDA inspection closed as VAI, and its GMP is recognised in 1 market.

US DMF
None on file
CEP
1 valid
Last FDA inspection
2019 · VAI
GMP recognised in
1 markets
How this listing is sourced EDQM certificate database
View profile
19

Matrix Pharmacorp

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for gabapentin, filing since 2005. Its 2025 FDA inspection closed as VAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile

31 more manufacturers hold filings for gabapentin

The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.

OlonHeteroJiangxi Synergy PharmaceuticalSaraca LaboratoriesGranules IndiaAnjan DrugZhejiang Yongtai Chiral Medicine TechnologyApitoria PharmaZhejiang Apeloa Jiayuan PharmaceuticalZhejiang Excel PharmaceuticalErregierreF.I.S. – Fabbrica Italiana SinteticiZhejiang Bamboo Pharmaceuticals Co.,LtdEmnar PharmaIOL Chemicals and PharmaceuticalsMatrix PharmacorpHikal
Open the full list with a free account

Contract manufacturers (7)

Divi's Laboratories India Hikal India F.I.S. – Fabbrica Italiana Sintetici Italy Metrochem API India Xl Laboratories India Acme Generics India Olon Italy

Contract manufacturers make to order rather than holding their own filing for this molecule.

Finished-dose makers (107)

Viatris United States Glenmark Pharmaceuticals s.r.o Czech Republic Amneal United States Teva Israel Eurofarma Laboratorios Brazil Zydus Lifesciences India Sandoz Switzerland Pharmascience Canada Stallion Laboratories India Apotex Canada Ajenat Pharmaceuticals United States Cipla India Epic Pharma United States Laurus Labs India ScieGen Pharmaceuticals United States Zentiva, k.s Czech Republic Micro Labs India Fresenius Kabi Ab Sweden HIKMA ITALIA Italy Torrent Pharmaceuticals India

How this list is built

The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.

Active US DMFs
FDA, List of Drug Master Files
Valid CEPs
EDQM certificate database
Inspection outcomes
FDA inspection classifications
GMP certificates
EudraGMDP and national regulators
Price band
Customs export unit values for 2025. These are export values rather than contract prices for regulated-market grade material, which are higher.

Map gabapentin for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

Also on this molecule

Price history 4 yrs Shortages 339 Recalls 18 Finished dose 107 Contract mfrs 7

By country

India 20 China 11 Italy 6

Export price by year

Year Median Exporters
2026 YTD $30.03 18
2025 $30.00 55
2024 $32.50 41
2023 $38.30 36

US dollars per kilogram, customs export unit values.